Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)

Funding to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines.
Source: PHPartners.org - Category: International Medicine & Public Health Source Type: news